| 000 | 01221 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250512155000.0 | ||
| 264 | 0 | _c19691201 | |
| 008 | 196912s 0 0 eng d | ||
| 022 | _a0007-1188 | ||
| 024 | 7 |
_a10.1111/j.1476-5381.1969.tb09522.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCalne, D B | |
| 245 | 0 | 0 |
_aThe metabolism of orally administered L-Dopa in Parkinsonism. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cSep 1969 |
||
| 300 |
_a57-68 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aChromatography, Gas |
| 650 | 0 | 4 |
_aDihydroxyphenylalanine _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNorepinephrine _xmetabolism |
| 650 | 0 | 4 |
_aParkinson Disease _xmetabolism |
| 650 | 0 | 4 |
_aPhenylacetates _xurine |
| 650 | 0 | 4 |
_aPhenylpyruvic Acids _xmetabolism |
| 650 | 0 | 4 |
_aVanilmandelic Acid _xurine |
| 700 | 1 | _aKaroum, F | |
| 700 | 1 | _aRuthven, C R | |
| 700 | 1 | _aSandler, M | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 37 _gno. 1 _gp. 57-68 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1476-5381.1969.tb09522.x _zAvailable from publisher's website |
| 999 |
_c5344871 _d5344871 |
||